NASDAQ : IMMP
Immutep Limited — Key statistics
Healthcare · Biotechnology · Australia
Last price 3.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 23.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 22.88M |
| Enterprise Value | -24.83M |
Dates
| Measure | Value |
|---|
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +1.08% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 4.64% |
| Owned by Institutions (%) | 57.06% |
| Float | 1.37B |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| Forward PS | 4.30 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.69 |
| Quick Ratio | 5.54 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,201.71 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -77.31% |
| Return on Assets (ROA) | -42.45% |
| Return on Invested Capital (ROIC) | -49.07% |
| Return on Capital Employed (ROCE) | -118.07% |
| Weighted Average Cost of Capital (WACC) | 16.55% |
| Revenue Per Employee | $444,853 |
| Profits Per Employee | -$1.77M |
| Employee Count | 31 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.30 |
| 52-Week Price Change | -91.97% |
| 50-Day Moving Average | 5.16 |
| 200-Day Moving Average | 16.82 |
| Relative Strength Index (RSI) | 23.72 |
| Average Volume (20 Days) | 16,270 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 33,547 |
| Short Previous Month | 46,784 |
| Short % of Shares Out | 0.97% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.48 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.79M |
| Gross Profit | -49.82M |
| Operating Income | -56.45M |
| Pretax Income | -54.86M |
| Net Income | -54.86M |
| EBITDA | -54.93M |
| EBIT | -56.45M |
| Loss Per Share | -$7.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 47.65M |
| Total Debt | 724,681 |
| Net Cash | 46.92M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 42.57M |
| Book Value Per Share | 0.03 |
| Working Capital | 45.98M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -38.93M |
| Capital Expenditures | -65,223 |
| Depreciation & Amortization | 1.54M |
| Net Borrowing | -150,494 |
| Free Cash Flow | -38.99M |
| FCF Per Share | -$0.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | -409.31% |
| Pretax Margin | -397.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.08% |
| Shareholder Yield | -1.08% |
| Earnings Yield | -246.44% |
| FCF Yield | -170.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -53.53% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 28, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.3 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |